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Correction. In the article "Diphenylhydantoin (Dilantin) gingival hyperplasia: Drug-induced abnormality of connective tissue" by T. M. Hassell, R. C. Page, A. S. Narayanan, and C. G. Cooper, which appeared in the August 1976 issue of Proc. Natl. Acad. Sci. USA 73, 2909-2912, the authors have requested changes in the protein data in Table 2 7.7 at 25°), were centrifuged at 100,000 X g for 60 min, and the supernatant was heated for 15 min in a boiling-water bath. The boiled homogenate was centrifuged at 100,000 X g for 60 min and the supernatant was lyophilized. The powder was extracted in methanol (20 vol/wt) and the methanol was evaporated at 300. The residue, dissolved in 20 ml of 50 mM Tris-HCI buffer (pH 7.7 at 250), was applied to a Biogel P2 column (95 X 3.1 cm) that was prepared and eluted in the same buffer. Fractions 21-29 were pooled, lyophilized, and resuspended in 20 ml of 100 mM NH4-acetate buffer, pH 7.4, applied to a column of AG-1-X2 (200-400 mesh, Bio-Rad, 35 X 1.8 cm), and prepared and washed with 150 ml of the NH4-acetate buffer. The column was eluted with a linear pH gradient of 250 ml of 100 mM NH4-acetate buffer, pH 7.4, and 250 ml of 100 mM acetic acid. Fractions (7 ml) with peak opioid activity (eluted at pH 5.6-5.9) were pooled, lyophilized, suspended in 10 mM HC1, and applied to a column of AG-SOW-X2 (200-400 mesh, Bio-Rad, 25 X 1.1 cm) prepared in 10mM HCI. Fractions were eluted, first successively with 100 ml of 10 mM HCI and 100 ml of 100 mM NH4-acetate buffer, pH 7.4, and then with a linear pH gradient of 250 ml of 100 mM NH4-acetate buffer, pH 7.4, and 250 ml of 100 mM NH40H. Five-milliliter fractions were lyophilized, * To whom reprint requests should be sent. suspended in 0.5 ml of H20, and assayed for opiate receptor activity. The peak fractions were applied to an Amberlite CG-400 column ( Step of purification equivalent) (-fold) Enkephalin activity was assayed as in Materials and Methods. The purification scheme was repeated three times, with less than 20% variation in extent of purification in all steps. The amino acid sequence was investigated by the sequential degradation dansyl-Edman procedure (20) . The carboxylterminal was determined by incubating 10 nmol of enkephalin for 0-15 min in H20 at 25°on a 0.5 X 3 cm column of carboxypeptidase A bound to Sepharose (Worthington Biochemical Co.). The eluate (10 ml) from the carboxypeptidase column was Iyophilized and dansylated, and amino acids were determined by chromatography on polyamine sheets. Relative amounts of the dansylated amino acids were quantified by comparison to 0.01-1 nmol of standard dansylated amino acids. The polyamine sheets (7.5 X 7.5 cm) were placed in two solvents: (i) H20-90% formic acid (200:3, vol/vol), and (ii) benzene-glacial acetic acid (0:1, vol/vol). A third solvent, n-heptane-butanolglacial acetic acid (3:3:1, vol/vol/vol) gave similar results.
Synthetic peptides Tyr-Gly-Gly-Phe-Leu and Tyr-GlyGly-Phe-Met were a generous gift of Dr. D. Hauser and Dr. F. Cardinaux, Sandox, Ltd., Switzerland.
Opioid activity was assayed as the ability to inhibit specific [3H]naloxone (New England Nuclear Corp., 20 Ci/mmol) binding to rat brain membranes (21) as previously described (15) . One unit of opioid activity "enkephalin" was defined as that amount that yields 50% occupancy in a 200-pi assay, according to Colquhoun (22) .
RESULTS
Purification and Isolation of Enkephalin. We isolated apparently homogeneous enkephalin by a six-step purification. Almost all activity is extracted into absolute methanol, with a 4.6-fold purification (Table 1) . Biogel P2 columns give a further 7-fold purification. The AG-1-X2, AG-50W-X2, and Amberlite-CG-400 ion exchange columns provide successive enrichments of 13-fold, 12-fold, and 5-fold ( Figs. 1 and 2 ; Table 1 ). Activity elutes from the Amberlite-CG-400 column in a single peak at pH 5.6-5.9 (Fig. 2) , and subsequent high-voltage paper electrophoresis at pH 2 resolves enkephalin from other fluorescamine-reactive material, yielding apparently homogeneous enkephalin.
Assessment of Enkephalin Purity and Determination of Amino Acid Composition and Sequence. In Biogel P2 chromatography, enkephalin purified through the electrophoresis step elutes as a single peak corresponding to the only peak of fluorescamine-reactive material, reflecting an apparent molecular weight of about 1000 (Fig. 3) . High-voltage paper electrophoresis at pH 2 and pH 6.5 reveals single peaks of fluorescamine-reactivity and enkephalin activity. At pH 2, enkephalin activity migrates toward the anode slightly behind aspartic acid, indicating an approximate molecular weight of 600-800 (23), like pig brain enkephalin (5, 14) . At pH 6.5, bovine brain enkephalin activity migrates very slightly toward the anode, like glycine and valine, so at this pH enkephalin lacks a strong charge (Fig. 3) .
After dansylation and HC1 hydrolysis a single spot on polyamine sheets corresponds to bis-tyrosine, indicating a single NH2-terminal amino acid, tyrosine. Hydrolysis after dansylation with 3 M p-toluenesulfonic acid containing 0.2% 3-(2-amino-ethylinode) reveals no tryptophan.
Amino acid composition, assessed by dansylation after HO1 hydrolysis and polyamine sheet chromatography, shows glycine, tyrosine, phenylalanine, leucine, and methionine. Spots for tyrosine, phenylalanine, and leucine are of equal intensity, whereas the spot for methionine is substantially weaker and that for glycine is more intense. Total hydrolysis with 3 M mercaptoethanesulfonic acid reveals no tryptophan.
The amino acid sequence was determined by dansyl-Edman sequence determination. The NH2-terminal amino acid is confirmed as tyrosine, and the second, third, and fourth amino acids correspond to glycine, glycine, and phenylalanine, respectively. In repeated experiments the fifth amino acid in the sequence appears to consist of both leucine and methionine, (Fig. 3) . In high-voltage paper electrophoresis at pH values of 2.0 and 6.5, natural enkephalin migrates as a single sharp peak, identical to those of synthetic Leu-enkephalin and Met-enkephalin (Fig. 3) .
Interactions of Natural and Synthetic Enkephalins with the Opiate Receptor. Hughes et al. (14) found Met-enkephalin about three times as potent as morphine in inhibiting [3H]naloxone binding in sodium-free homogenates of guinea pig brain.
In the absence of sodium, native enkephalin inhibits [3H]naloxone binding with an IC;5o (median inhibitory concentration) of 24 nM, the same as Leu-enkephalin, whereas Met-enkephalin is about three to four times more potent (Table 2) . Even at 1 ,uM, the tripeptide Tyr-Gly-Gly fails to alter [3H]naloxone binding.
Sodium but not potassium decreases receptor binding of opiate agonists while enhancing binding of antagonists (24) , whereas manganese but not calcium enhances agonist but not antagonist binding (25) . At 10 mM NaCl natural and synthetic enkephalins become less potent in competing for [3Hjnaloxone binding, an agonist profile, whereas competition by nonradioactive naloxone is unaffected. Potassium fails to alter the potencies of natural and synthetic enkephalins and morphine. With 0.25 mM manganese, morphine and synthetic and natural enkephalins become more potent in inhibiting [3H]naloxone. binding, whereas calcium is ineffective. Sodium diminishes potencies of natural enkephalin and synthetic Leu-enkephalin six to seven times, whereas manganese enhances potency 4-fold. By contrast, Met-enkephalin is reduced in potency only 3.75-fold by sodium and is enhanced in potency 3.0-fold by manganese. The closely similar effect of these ions upon natural enkephalin and Leu-enkephalin is consistent with our observation that about 80% of natural enkephalin consists of Leuenkephalin. The more marked influences of sodium on-receptor interactions of leucine than of methionine enkephalin suggest that Leu-enkephalin is a "purer" agonist than Met-enkephalin. DISCUSSION Guillemin et al. (26) identified a hexadecapeptide "a-endorphine" in pig neurohypophysis-hypothalamus incorporating the Met-enkephalin sequence and with guinea pig ileum potency resembling Met-enkephalin. Alpha-endorphine corresponds to fragments 61-76 of the pituitary peptide ,B-lipotropin
